Cargando…
Development of acquired factor V inhibitor after treatment with ceftazidime: a case report and review of the literature
We report the case of a 59-year-old Chinese man who showed an asymptomatic coagulation factor V deficiency pattern after second intravenous treatment with ceftazidime. Normal pooled plasma failed to correct the abnormalities in a mixing test, and the presence of factor V inhibitor was confirmed by t...
Autores principales: | Cui, Qing-ya, Shen, Hong-shi, Wu, Tian-qin, Chen, Hai-fei, Yu, Zi-qiang, Wang, Zhao-yue |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4422287/ https://www.ncbi.nlm.nih.gov/pubmed/25987837 http://dx.doi.org/10.2147/DDDT.S68682 |
Ejemplares similares
-
Jerky Movement with Ceftazidime: A Case of Ceftazidime-Induced Neurotoxicity with a Review of the Literature
por: Al-Sadawi, Mohammed, et al.
Publicado: (2019) -
Ceftazidime/Avibactam Resistance in Carbapenemase-Producing Klebsiella pneumoniae
por: Cui, Qiaozhen, et al.
Publicado: (2023) -
Ceftazidime-avibactam
por: Matesanz, Mayra, et al.
Publicado: (2021) -
Ceftazidime-avibactam
por: Herrero, Francisco Sanz
Publicado: (2022) -
Ceftazidime-Avibactam for Hospital Acquired Pneumonia Due to Extended Drug-Resistant Klebsiella pneumoniae
por: Rup, Amit Ranjan, et al.
Publicado: (2020)